HomeInsightsShare Holding

Shilpa Medicare Ltd Share Holding Pattern

Shilpa Medicare Ltd Share Holding Pattern

stocks purchased

₹ 2.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

28.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Promoters Holdings Over Time

Key Highlights

  • Mutual funds increased their stake in the company by 0.02% from March 2024 to June 2024.
  • FIIs/FPIs decreased their stake in the company by 0.60% from March 2024 to June 2024.

Latest Shareholding

Market Price of Shilpa Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024911
21 Nov 2024935.8
19 Nov 2024879.9
18 Nov 2024863.4
14 Nov 2024872.9
13 Nov 2024824.75
12 Nov 2024878.05
11 Nov 2024893.2
08 Nov 2024852.7
07 Nov 2024843.4

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine

Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...

Read more

19 Nov 202411:24

News

Shilpa Medicare rallies after robust Q2 results

Profit before tax (PBT) surged 300.98% to Rs 36.77 crore in Q2 FY25 over Q2 FY24. EBITDA j...

Read more

14 Nov 202410:39

News

Shilpa Medicare update on its CDMO partner - Unicycive Therapeutics

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has announced that the U.S. Food and Drug Admi...

Read more

12 Nov 202415:02

News

Shilpa Medicare schedules board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...

Read more

04 Nov 202418:42

News

Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility

In a regulatory filing made during market hours today, the company informed the company's ...

Read more

31 Oct 202413:43

News

Shilpa Medicare arm gets CEP from EDQM for Desmopressin

Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid...

Read more

04 Oct 202408:40

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Shilpa Medicare Ltd

On what factors does the shareholding pattern of Shilpa Medicare Ltd change frequently?

The shareholding pattern of Shilpa Medicare Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Shilpa Medicare Ltd's shareholding pattern updated?

The Shilpa Medicare Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Shilpa Medicare Ltd?

Categories included in the shareholding pattern of Shilpa Medicare Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Shilpa Medicare Ltd important for investors?

The shareholding pattern of Shilpa Medicare Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Shilpa Medicare Ltd?

The latest shareholding pattern of Shilpa Medicare Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*